MONIR CHAUDHRY: Open Payments
NPI 1740334267 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 41 payments from 10 companies in 2025. Trend: 2023 $585 · 2024 $909 · 2025 $783
Food & beverage: $681Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $242 |
| ABBVIE INC. | 10 | $151 |
| Supernus Pharmaceuticals, Inc. | 5 | $99 |
| Alkermes, Inc. | 5 | $93 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Lundbeck LLC | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, Qelbree, REXULTI, ARISTADA, UZEDY, AUSTEDO XR, INVEGA SUSTENNA, COBENFY.
Industry payments across NY — which companies pay providers there.
